NIH-funded research R01 grant

Lactate and immune recovery after sepsis

Official title: Novel Role of Lactate in Sepsis Impaired Immune Function

Funded at East Tennessee State University · NIH-11228791 · Data updated 2026-11-12

This project looks at whether high lactate levels after sepsis make immune cells age and stop working, increasing the chance of new infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEast Tennessee State University
NIH-funded
Lab location1 site (Johnson City, United States)
Project startDecember 12, 2023
Project endOctober 31, 2028
Funding year2026
Award (this year)$576,326
NIH project number5R01AI174020-03
Project IDNIH-11228791 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be adults who have recently survived sepsis or who can provide clinical data or blood samples related to a sepsis episode.

Less likely to help

People without a history of sepsis or those who are children or medically unstable for study procedures are unlikely to benefit directly from participating.

What this research studies

If you survived sepsis, this work aims to explain why your immune system may stay weak by studying how lactate affects immune cells. Researchers will combine clinical data with lab experiments including mouse models and cell studies to track macrophage function, signs of cellular aging, and changes in key proteins. They will use RNA sequencing and biochemical tests to see how lactate changes gene activity and causes 'lactylation' of proteins like YAP that protect cells from aging. The team will measure infection survival, immune cell phagocytosis, and markers of senescence to connect these lab findings to sepsis outcomes.

Why it matters

Potential benefit: If successful, this could point to new ways to prevent or treat immune weakening after sepsis and reduce later infections.

How similar studies have gone: Clinical data already links high lactate to worse sepsis outcomes and preclinical work shows lactate affects immune cells, but linking lactate-driven protein 'lactylation' and YAP-related immune aging is a new direction.

Where this research is happening

  • East Tennessee State University
    Johnson City, United States
    Active

Researchers

  • Principal investigator: Li, Chuanfu — East Tennessee State University
  • Study coordinator: Li, Chuanfu

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.